“Alexion is a company that for 25 years has dedicated its activity to the development and commercialization of innovative therapies focusing totally on the field of rare diseases. The value we try to bring is related to the fact of making innovative therapies available to patients and also services that can improve their quality of life. There are about 7,000 rare diseases in the world, in Italy it is estimated that there are more than a million patients affected by rare diseases and only about 5% of these diseases there are effective treatments. So the possibility of investing in research and development and having companies that can help find solutions for these people and their families is certainly important “. This was stated by Anna Chiara Rossi, Alexion CEO in Italy, on the occasion of the VIII edition of the OMaR Award on rare diseases which was held in Rome at the Ara Pacis.
#Rare #diseases #Rossi #Alexion #years #working #innovative #therapies #services #improve #quality #life